Multi-Center Clean Air Randomized Controlled Trial in COPD (NCT06376994)
🩺 Plain-English Summary (8th-Grade Level)
This is a multi-center randomized, sham-controlled clinical trial to determine the effectiveness of an air cleaner intervention aimed at improving indoor air quality on reducing COPD exacerbation risk and improving quality of life, functional status, rescue medication use.
Who can join: Review the eligibility criteria below.
Location: University of Alabama, Lung Health Center — Birmingham, Alabama
Age range: 40 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (11 Sites)
- University of Alabama, Lung Health Center — Birmingham, Alabama
- University of California, Los Angeles — Los Angeles, California
- University of Iowa — Iowa City, Iowa
- University of Maryland — Baltimore, Maryland
- Johns Hopkins — Baltimore, Maryland
- Tidal Health — Salisbury, Maryland
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- University of Michigan — Ann Arbor, Michigan
- Dartmouth Hitchcock — Lebanon, New Hampshire
- Cleveland Clinic — Cleveland, Ohio
- Reading Hospital — West Reading, Pennsylvania
📞 Contact the Study Coordinator
Phone: (410) 502-3872
Email: sehrhar6@jhu.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Chronic Obstructive Pulmonary Disease (COPD)
- Laying the Foundation for Building a Resilient KPNC Community in the Face of Worsening Air Quality Due to Wildfire Smoke — Pleasanton, California
- A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease — Birmingham, Alabama
- WearME-Pro Phase II: Remote Use Usability and Longitudinal Validation Study (Patch Form Factor). — Baltimore, Maryland
- Investigating Senolytic Properties in Pulmonary Rehabilitation and Metformin in COPD Exacerbations — Durham, North Carolina
- To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment — Phoenix, Arizona
Explore by condition: All Chronic Obstructive Pulmonary Disease (COPD) clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.